Literature DB >> 31278063

Value of monopolar and bipolar radiofrequency ablation for the treatment of benign thyroid nodules.

Harald Dobnig1, Karin Amrein2.   

Abstract

Only a few thyroid nodules are perceived as functional or optically disturbing. If there is a need for action, surgical intervention is the long-term standard by which thermoablative procedures (radiofrequency-, laser-, microwave ablation, high intensity focused ultrasound) must be measured against in terms of safety, effectiveness and patient satisfaction. Prior to intervention assessment of the dignity of the nodule by ultrasound-guided fine needle aspiration is essential for cold and warm nodules, as is the confirmation of an inconspicuous cervical lymph node status. The short-term treatment results of these newer interventions in terms of nodule volume reduction and symptomatic improvement are promising and the general complication rate of the procedures is low. Since functional thyroid parenchyma is preserved, maintaining normal thyroid status is the rule. The procedure is usually performed on an outpatient basis, under local anesthesia and monitoring. The subsequent convalescence is usually very short. Most studies are available on monopolar radiofrequency ablation. Several professional societies have defined indications for radiofrequency ablation (RFA), but these need to be further refined based on practical experience and literature. An acceptable long-term recurrence rate still has to be proven for practically all thermoablative methods, for monopolar RFA limited long-term data are encouraging so far. The recurrence rate as well as patient satisfaction will provide the basis for a meaningful overall cost-benefit analysis in the future.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  RFA; autonomous nodule; cystic nodule; laser ablation; thermoablation; thyroid nodule

Mesh:

Year:  2019        PMID: 31278063     DOI: 10.1016/j.beem.2019.05.007

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  5 in total

1.  Efficacy and safety of radiofrequency ablation for calcified benign thyroid nodules: results of over 5 years' follow-up.

Authors:  Yi Li; Hongying He; Wen Li; Jiahang Zhao; Naiqiao Ge; Yan Zhang; Yukun Luo
Journal:  BMC Med Imaging       Date:  2022-04-22       Impact factor: 2.795

2.  A novel parallel overlapping mode for complete ablation of large benign thyroid nodules in a single-session radiofrequency ablation.

Authors:  Tao Wu; Bowen Zheng; Lei Tan; Tinghui Yin; Yufan Lian; Shicheng Xu; Jin Ye; Jie Ren
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-26       Impact factor: 6.055

3.  Long-Term Results of Ultrasound-Guided Radiofrequency Ablation of Benign Thyroid Nodules: State of the Art and Future Perspectives-A Systematic Review.

Authors:  Hervé Monpeyssen; Ahmad Alamri; Adrien Ben Hamou
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-26       Impact factor: 5.555

4.  Radiofrequency ablation of benign thyroid nodules: recommendations from the Asian Conference on Tumor Ablation Task Force.

Authors:  Eun Ju Ha; Jung Hwan Baek; Ying Che; Yi-Hong Chou; Nobuhiro Fukunari; Ji-Hoon Kim; Wei-Che Lin; Le Thi My; Dong Gyu Na; Lawrence Han Hwee Quek; Ming-Hsun Wu; Koichiro Yamakado; Jianhua Zhou
Journal:  Ultrasonography       Date:  2020-09-08

5.  Matrix 3D ultrasound-assisted thyroid nodule volume estimation and radiofrequency ablation: a phantom study.

Authors:  T Boers; S J Braak; M Versluis; S Manohar
Journal:  Eur Radiol Exp       Date:  2021-07-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.